To investigate possible roles of the Arf6–AMAP1 pathway in ROS regulation, we chose the highly invasive breast cancer cell line MDA-MB-231 as an experimental model, because we previously used these cells to analyze cancer invasion and integrin recycling mediated by this pathway22,26–28. Here, ARF6 is linked to breast carcinoma.